These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
181 related items for PubMed ID: 3788761
1. Comparison of intravenous mexiletine and lidocaine for the treatment of ventricular arrhythmias. Lui HK, Harris FJ, Chan MC, Lee G, Mason DT. Am Heart J; 1986 Dec; 112(6):1153-8. PubMed ID: 3788761 [Abstract] [Full Text] [Related]
2. Prediction of efficacy and tolerance of oral mexiletine by intravenous lidocaine application. Zehender M, Geibel A, Treese N, Hohnloser S, Meinertz T, Just H. Clin Pharmacol Ther; 1988 Oct; 44(4):389-95. PubMed ID: 3168391 [Abstract] [Full Text] [Related]
3. Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing. Murray KT, Barbey JT, Kopelman HA, Siddoway LA, Echt DS, Woosley RL, Roden DM. Clin Pharmacol Ther; 1989 May; 45(5):553-61. PubMed ID: 2498025 [Abstract] [Full Text] [Related]
4. Comparison of intravenous lorcainide with lidocaine for acute therapy of complex ventricular arrhythmias: results of a randomized study with crossover option. Anderson JL, Anastasiou-Nana M, Lutz JR, Writer SL. J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):333-41. PubMed ID: 3881497 [Abstract] [Full Text] [Related]
5. A study to compare the efficacy, plasma concentration profile and tolerability of conventional mexiletine and slow-release mexiletine. Upward JW, Holt DW, Jackson G. Eur Heart J; 1984 Mar; 5(3):247-52. PubMed ID: 6723694 [Abstract] [Full Text] [Related]
6. Disopyramide and mexiletine: which is the agent of choice in the long term-oral treatment of lidocaine-responsive arrhythmias? Efficacy comparison in a randomized trial. Trimarco B, Volpe M, Ricciardelli B, Sacca' L, De Luca N, Rengo F, Condorelli M. Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):251-9. PubMed ID: 7013721 [Abstract] [Full Text] [Related]
7. Conversion from intravenous to oral mexiletine in the acute management of repetitive ventricular arrhythmia. Horowitz LN, Greenspan AM, Spielman SR, Frye SJ, Yacone LA, Lowenthal DT. Clin Pharmacol Ther; 1985 Jun; 37(6):644-8. PubMed ID: 2408808 [Abstract] [Full Text] [Related]
8. Efficacy and safety of intravenous tocainide compared with intravenous lidocaine for acute ventricular arrhythmias immediately after cardiac surgery. Morganroth J, Panidis IP, Harley S, Johnson J, Smith E, MacVaugh H. Am J Cardiol; 1984 Dec 01; 54(10):1253-8. PubMed ID: 6439023 [Abstract] [Full Text] [Related]
9. Mexiletine: an effective antiarrhythmic drug for treatment of ventricular arrhythmias in congenital heart disease. Moak JP, Smith RT, Garson A. J Am Coll Cardiol; 1987 Oct 01; 10(4):824-9. PubMed ID: 3655149 [Abstract] [Full Text] [Related]
15. [Treatment of ventricular arrhythmia with mexiletine (Mexitil), monitored by Holter ambulatory electrocardiography]. Garimoldi M, Pirastu A, Barbanotti G, Sghirinzetti M, Catalano M, Castelfranco M. Minerva Cardioangiol; 1988 Apr 01; 36(4):159-65. PubMed ID: 3173699 [No Abstract] [Full Text] [Related]
16. Mexiletine in the treatment of ventricular arrhythmias. Henrard L, Carlier J. Acta Cardiol Suppl; 1980 Apr 01; (25):127-35. PubMed ID: 6966452 [Abstract] [Full Text] [Related]
17. Clinical evaluation of oral mexiletine therapy in the treatment of ventricular arrhythmias. Rutledge JC, Harris F, Amsterdam EA. J Am Coll Cardiol; 1985 Oct 01; 6(4):780-4. PubMed ID: 4031292 [Abstract] [Full Text] [Related]